Literature DB >> 18528924

Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know.

Rolv-Ole Lindsetmo, Yong-Geul Joh, Conor-P Delaney.   

Abstract

Rectal cancer accounts for one third of all colorectal cancers. The age adjusted death rates from colorectal cancer have declined over recent decades due to a combination of colorectal cancer screening, improved diagnostic tests, improved standardized surgical technique, improved medical support, neoadjuvant chemotherapies and radiation treatment or combinations of these. Because of complex treatment algorithms, use of multidisciplinary teams in the management of rectal cancer patients has also been popularized. Medical gastroenterologists performing colonoscopies are frequently the first health care provider to raise the suspicion of a rectal cancer. Although the diagnosis depends on histological confirmation, the endoscopic presentation is almost diagnostic in many cases. In order to meet the patient's immediate needs for information, it is important that the endoscopist has knowledge about the investigations and treatment options that will be required for their patient. The aim of this paper is to describe the modern preoperative investigations and operative procedures commonly offered to rectal cancer patients taking into account perspectives of three colorectal surgeons, practicing in the USA, Europe and Asia.

Entities:  

Mesh:

Year:  2008        PMID: 18528924      PMCID: PMC2716581          DOI: 10.3748/wjg.14.3281

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  59 in total

Review 1.  Neoadjuvant and adjuvant therapy for rectal cancer.

Authors:  J Pablo Arnoletti; Kirby I Bland
Journal:  Surg Oncol Clin N Am       Date:  2006-01       Impact factor: 3.495

2.  Laparoscopic versus open surgery for rectal cancer: a meta-analysis.

Authors:  Omer Aziz; Vasilis Constantinides; Paris P Tekkis; Thanos Athanasiou; Sanjay Purkayastha; Paraskevas Paraskeva; Ara W Darzi; Alexander G Heriot
Journal:  Ann Surg Oncol       Date:  2006-02-01       Impact factor: 5.344

3.  Recurrence after transanal excision of T1 rectal cancer: should we be concerned?

Authors:  Khaled M Madbouly; Feza H Remzi; Bulent A Erkek; Anthony J Senagore; Christen M Baeslach; Farah Khandwala; Victor W Fazio; Ian C Lavery
Journal:  Dis Colon Rectum       Date:  2005-04       Impact factor: 4.585

4.  Metastatic potential in T1 and T2 colorectal cancer.

Authors:  Wen-Liang Fang; Shih-Ching Chang; Jen-Kou Lin; Haunn-Sheng Wang; Shung-Haur Yang; Jen-Kae Jiang; Wei-Chone Chen; Tzu-Chen Lin
Journal:  Hepatogastroenterology       Date:  2005 Nov-Dec

5.  Diagnosis-related group assignment in laparoscopic and open colectomy: financial implications for payer and provider.

Authors:  Anthony J Senagore; Ann Brannigan; Ravi P Kiran; Karen Brady; Conor P Delaney
Journal:  Dis Colon Rectum       Date:  2005-05       Impact factor: 4.585

6.  T1 adenocarcinoma of the rectum: transanal excision or radical surgery?

Authors:  David J Bentrem; Satoshi Okabe; W Douglas Wong; Jose G Guillem; Martin R Weiser; Larissa K Temple; Leah S Ben-Porat; Bruce D Minsky; Alfred M Cohen; Philip B Paty
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

7.  Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Desidério Roberto Kiss; Viviane Rawet; Arceu Scanavini; Pedro Marcos Santinho; Wladimir Nadalin
Journal:  Hepatogastroenterology       Date:  2004 Nov-Dec

Review 8.  Modern management of rectal cancer: a 2006 update.

Authors:  Glen-C Balch; Alex De Meo; Jose-G Guillem
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

9.  Multivariable analysis of factors associated with hospital readmission after intestinal surgery.

Authors:  Yehuda Kariv; Wei Wang; Anthony J Senagore; Jeffrey P Hammel; Victor W Fazio; Conor P Delaney
Journal:  Am J Surg       Date:  2006-03       Impact factor: 2.565

10.  Clinical results of intraoperative radiation therapy for patients with locally recurrent and advanced tumors having colorectal involvement.

Authors:  Christina P Williams; Harry L Reynolds; Conor P Delaney; Brad Champagne; Vincent Obias; Yong-Geul Joh; Jim Merlino; Timothy J Kinsella
Journal:  Am J Surg       Date:  2008-03       Impact factor: 2.565

View more
  5 in total

1.  Laparoscopic vs open abdominoperineal resection in the multimodality management of low rectal cancers.

Authors:  Yu-Wei Wang; Li-Yong Huang; Cheng-Li Song; Chang-Hua Zhuo; De-Bing Shi; Guo-Xiang Cai; Ye Xu; San-Jun Cai; Xin-Xiang Li
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

2.  Lymphovascular invasion in rectal cancer following neoadjuvant radiotherapy: a retrospective cohort study.

Authors:  Chang-Zheng Du; Wei-Cheng Xue; Yong Cai; Ming Li; Jin Gu
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

Review 3.  Colorectal cancer: from prevention to personalized medicine.

Authors:  Gemma Binefa; Francisco Rodríguez-Moranta; Alex Teule; Manuel Medina-Hayas
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

4.  Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.

Authors:  Hideomi Yamashita; Soichiro Ishihara; Hiroaki Nozawa; Kazushige Kawai; Tomomichi Kiyomatsu; Kae Okuma; Osamu Abe; Toshiaki Watanabe; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2017-09-21       Impact factor: 3.481

5.  Comparison of pathologic outcomes of robotic and open resections for rectal cancer: A systematic review and meta-analysis.

Authors:  Yinyin Guo; Yichen Guo; Yanxin Luo; Xia Song; Hui Zhao; Laiyuan Li
Journal:  PLoS One       Date:  2021-01-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.